Here's Won't Touch Teva: Why I Pass on the Generic Giant
Teva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Zero Based Budgeting strengthens financial health by ensuring every dollar serves a purpose and aligns with goals.
24,601 articlesTeva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Energy markets moved on geopolitical headlines, lifting ConocoPhillips stock in intraday trading. This article explai...
Institutions are back in force for Bitcoin, led by US Bitcoin ETFs and MicroStrategy buying. Flows total about $1.25B...
Ethereum flirted with a major resistance around $2,160 before pulling back toward $2,080. Traders weigh whether this ...
As earnings season winds down, March can be a smart time to add leading tech stocks to your portfolio. Explore three ...
Rezervology and Titl unveil RezeLink, an AI-native platform designed to speed title searches for SoftPro users, boast...
The voting tech firm Smartmatic has filed to dismiss a money laundering indictment, arguing political pressure shaped...
BYDFi's perpetual futures data now streams into TradingView, giving traders real-time crypto derivatives insights wit...
A JPMorgan analysis shows a striking split in ETF flows since late February, with Bitcoin ETFs drawing money while go...
U.S. equities climbed on Friday as top performing stocks led a broad rally, with technology and energy names pushing ...
Dell Technologies rode a wave of AI server demand to a $33.4 billion quarterly revenue, beating expectations and lift...
One year into Lip-Bu Tan’s tenure, Intel trimmed costs, pushed 18A production forward, and rebuilt the balance sheet—...